ICAD INC (ICAD)

US44934S2068 - Common Stock

1.83  +0.06 (+3.39%)

After market: 1.83 0 (0%)

ICAD INC

NASDAQ:ICAD (12/20/2024, 8:17:46 PM)

After market: 1.83 0 (0%)

1.83

+0.06 (+3.39%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Technology
GICS SubIndustryHealth Care Technology
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%-40%
Sales Q2Q%3.54%
CRS75.21
6 Month28.87%
Overview
Earnings (Last)11-13 2024-11-13/amc
Earnings (Next)N/A N/A
Ins Owners5.63%
Inst Owners25.59%
Market Cap48.57M
Shares26.54M
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts84
Short Float %1.14%
Short Ratio0.98
IPO12-13 1984-12-13
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

ICAD Daily chart

Company Profile

iCAD, Inc. is a global medical technology company, which engages in the provision of cancer detection and therapy solutions. The company is headquartered in Nashua, New Hampshire and currently employs 67 full-time employees. Its ProFound Breast Health Suite enables medical providers and professionals to accurately and reliably identify where cancer may be hiding. Its Cancer Detection segment solutions include advanced artificial intelligence and image analysis workflow solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing the prevalent cancers earlier, a range of upgradeable computer-aided detection systems and workflow solutions for digital breast tomosynthesis, full-field digital mammography, magnetic resonance imaging and computed tomography. ProFound Suite offers 360-degree solutions for cancer detection, density assessment, and personalized risk evaluation, all based on a 2D or 3D mammogram’s collection of images. ProFound Density Assessment standardizes and simplifies breast density reporting, algorithmically examining a woman’s breast anatomy from the mammogram image.

Company Info

ICAD INC

98 Spit Brook Rd Ste 100

Nashua NEW HAMPSHIRE 03062

P: 16038825200

CEO: Michael Klein

Employees: 68

Website: https://www.icadmed.com/

ICAD News

News Image6 days ago - FinancialNewsMediaThe Next Wave of Health AI: Analysts Highlight Breakthroughs in Clinical Trials and Patient Care

USA News Group  Commentary Issued on behalf of Avant Technologies Inc.   Vancouver, BC – December 17, 2024  – USA News Group News Commentary – Artificial intelligence (AI) is on the brink of becoming a critical resource in healthcare, moving beyond its status as a novel concept. With over 800 FDA-cleared AI applications already in […]

News Image12 days ago - iCAD, Inc.SABCS 2024: New Research Assesses iCAD’s Image Based AI-Risk, Detection, and Breast Arterial Calcifications (BAC) Assessment Across Diverse Populations

Reveals Higher Prevalence of Breast Arterial Calcifications (BAC) in Breast Cancer Patients, Suggesting Potential Need for Cardiovascular Assessment...

News Image19 days ago - iCAD, Inc.CORRECTION – iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and ProFound Health Partnership with Cascaid Health at RSNA 2024

ProFound Health, a Virtual Care Partnership with Cascaid Health, to Democratize Access to AI-Powered Mammography for All Patients – Launching Q1 2025...

News Imagea month ago - iCAD, Inc.iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and a Second-Read AI Partnership with Cascaid Health at RSNA 2024

ProFound Health, a Virtual Care Partnership with Cascaid Health, to Democratize Access to AI-Powered Mammography for All Patients – Launching Q1 2025...

News Imagea month ago - iCAD, Inc.iCAD Reports Financial Results for Third Quarter Ended September 30, 2024

NASHUA, N.H., Nov. 13, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (

News Image2 months ago - iCAD, Inc.iCAD to Attend 15th Annual Craig-Hallum Alpha Select Conference

NASHUA, N.H., Nov. 06, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”) a global leader on a mission to create a world where...

ICAD Twits

Here you can normally see the latest stock twits on ICAD, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example